Pfizer offers a 5.7% dividend yield despite concerns over a 436% payout ratio, with a strong market position and promising drug pipeline.
Pfizer offers a 5.7% dividend yield, attracting investors despite concerns over a high payout ratio of 436%, the highest in its sector. While this raises sustainability issues, Pfizer's strong market position, commitment to maintaining dividends, and a promising drug pipeline suggest potential for recovery. The company aims to improve cash flow through a $4 billion savings plan, making it a noteworthy option for yield-seeking investors, albeit with caution advised.
6 months ago
3 Articles
Further Reading
This is your last free story for the month. Don’t miss out — Subscribe now for unlimited access!